These results suggest that apart from altering intestinal permeability, IBS-D FSN-mediated PAR-2 activation can also contribute to IBS-like visceral hypersensitivity through regulating release of BDNF from intestinal epithelium. This evidence concerns the gene F2RL1 and irritable bowel syndrome.